Stocktoria
Fresenius Medical Care AG FME.DE
DE · Deutsche Börse Xetra · XETR · stock · Healthcare · website
Fresenius Medical Care AG financials (annual)
Bars are annual figures from 2022 to 2025; red bars are negative (a loss or cash outflow).
| Metric | FY2025 | FY2024 | FY2023 | FY2022 |
|---|---|---|---|---|
| Revenue | €19.6B | €19.3B | €19.5B | €19.4B |
| Gross profit | €5.0B | €4.8B | €4.9B | €4.9B |
| R&D expense | €158.0M | €183.5M | €232.0M | €228.6M |
| SG&A expense | €3.0B | €3.1B | €3.2B | €3.2B |
| Operating income | €1.8B | €1.5B | €1.5B | €1.5B |
| Interest expense | €384.4M | €407.0M | €424.6M | €360.1M |
| Income tax | €321.0M | €316.1M | €300.6M | €325.0M |
| Net income | €978.4M | €537.9M | €499.0M | €673.4M |
| EPS (diluted) | €3.36 | €1.83 | €1.70 | €2.30 |
| Operating cash flow | €2.7B | €2.4B | €2.6B | €2.2B |
| Free cash flow | €1.8B | €1.7B | €1.9B | €1.4B |
| Cash & equivalents | €1.6B | €1.2B | €1.4B | €1.3B |
| Inventory | €2.1B | €2.1B | €2.2B | €2.3B |
| Goodwill | €13.6B | €15.2B | €14.7B | €15.8B |
| Total assets | €31.0B | €33.6B | €33.9B | €35.8B |
| Total debt | €10.8B | €11.0B | €12.1B | €13.2B |
| Total liabilities | €16.7B | €17.8B | €19.1B | €20.3B |
| Shareholders' equity | €13.3B | €14.6B | €13.6B | €14.0B |
| Share buybacks | €585.3M | €0 | €0 | €0 |
Growth · year-over-year · Revenue CAGR 0.4%
| Metric | FY2025 | FY2024 | FY2023 | FY2022 |
|---|---|---|---|---|
| Revenue growth | +1.5% | -0.6% | +0.3% | — |
| Net income growth | +81.9% | +7.8% | -25.9% | — |
| EPS growth | +83.6% | +7.6% | -26.1% | — |
| Free cash flow growth | +4.7% | -13.2% | +34.7% | — |
Each column is the change versus the prior fiscal year. Growth off a negative or zero base is shown as “—”. CAGR is the compound annual revenue growth across the years shown.
Computed from company filings · DE · as of 2025-12-31. Figures in EUR. Facts plus Stocktoria's own computed scores — not investment advice.